NCT00854633View on ClinicalTrials.gov

Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

March 31, 2012

Study Completion Date

December 31, 2012

Conditions
Nosocomial Infections
Interventions
DRUG

Talactoferrin

Enteral, 150 mg/kg twice per day

DRUG

Placebo

Oral, twice per day

Trial Locations (4)

40202

RECRUITING

Kosair Children's Hospital, Louisville

RECRUITING

University of Louisville Hospital, Louisville

65201

RECRUITING

University of Missouri Health Care, Columbia Regional Hospital, Columbia

90027

RECRUITING

Childrens Hospital of Los Angeles, Los Angeles

Sponsors

Lead Sponsor

Agennix
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Agennix

INDUSTRY

NCT00854633 - Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants | Biotech Hunter | Biotech Hunter